Somatropin long-acting - Delpor

Drug Profile

Somatropin long-acting - Delpor

Alternative Names: DLP-202; hGH - Delpor; Human growth hormone - Delpor

Latest Information Update: 15 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Delpor
  • Class Growth hormones; Hormonal replacements
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Somatotropin deficiency

Highest Development Phases

  • Research Somatotropin deficiency

Most Recent Events

  • 15 Aug 2016 Somatropin long-acting - Delpor is available for licensing as of 15 Aug 2016.
  • 15 Aug 2016 Early research in Somatotropin deficiency in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top